Vector Laboratories, part of Maravai LifeSciences, is a global market leader in labeling and detection reagents for immunohistochemistry, immunofluorescence, glycobiology and bioconjugation. Founded in 1976, its catalog of over 600 time-tested reagents and kits are used by disease and therapeutics researchers around the world and have been cited in over 350,000 peer reviewed scientific publications.
Location: United States, California, Burlingame
Employees: 51-200
Phone: +1 650-697-3600
Founded date: 1976
Investors 2
| Date | Name | Website |
| 07.09.2021 | Thompson S... | tscp.com |
| - | Audax Priv... | audaxpriva... |
Mentions in press and media 11
| Date | Title | Description |
| 27.03.2026 | Navinci to attend NextGen Omics and Spatial Biology US as silver sponsor and pre-launch new multiplex kit | Navinci to attend NextGen Omics and Spatial Biology US as silver sponsor and pre-launch new multiplex kit Fri, Mar 27, 2026 12:51 CET Report this content Uppsala, Sweden – March 27, 2026 – Navinci announced today its attendance at the Oxfor... |
| 18.03.2026 | Navinci and Vector Labs Highly Commended at CiteAb Awards 2026 | Navinci and Vector Labs Highly Commended at CiteAb Awards 2026 Wed, Mar 18, 2026 12:22 CET Report this content Uppsala, Sweden – March 17, 2026 – Navinci today announced that its collaborative work with Vector Laboratories has been highly c... |
| 25.07.2023 | Vector Laboratories Acquires Quanta BioDesign | Vector Laboratories, a Newark, CA-based pioneer of proteomic and glycomic research solutions, acquired Quanta BioDesign, the Plain City, OH-based inventor of discrete polyethylene glycol (dPEG®) technology for advanced bioconjugate and payl... |
| 30.12.2022 | The Art Of Presenting | Lisa V. Sellers, PhD, is CEO of Vector Laboratories. |
| 17.12.2021 | Risk, M&A and IPOs—here’s what mattered to CFOs this week | This is the web version of CFO Daily, a newsletter on the trends and individuals shaping corporate finance. Sign up to get it delivered free to your inbox. Good morning, Every Friday, I sum up the week. But before I do that, I’d like to sum... |
| 14.12.2021 | This was a big year for IPOs, but the struggle is real in a ‘perfect storm’ | This is the web version of CFO Daily, a newsletter on the trends and individuals shaping corporate finance. Sign up to get it delivered free to your inbox. Good morning, 2021 has been a record-breaking year for IPOs in the U.S. This year, I... |
| 07.09.2021 | Venture investors look for the next hot thing outside India and China | This is the web version of Term Sheet, a daily newsletter on the biggest deals and dealmakers. Sign up to get it delivered free to your inbox. Paid Content Does your company need a Chief A.I. Ethics Officer, an A.I. Ethicist, an A.I. Ethics... |
| 07.09.2021 | Vector Laboratories Completes $124 Million Buyout; Initiates Acquisition Strategy; Appoints Former 10x Genomics and Maravai LifeSciences Exec as CEO; Launches VectaMount Express | |
| 07.09.2021 | Venture investors look for the next hot thing outside India and China | This is the web version of Term Sheet, a daily newsletter on the biggest deals and dealmakers. Sign up to get it delivered free to your inbox. Paid Content How to ensure your marketers stay dynamic and agile From Optimizely In the hopes rid... |
| 07.04.2016 | Vector Laboratories Receives Strategic Investment from GTCR | Vector Laboratories, Inc., a Burlingame, California-based life science tools company, received a strategic investment of undisclosed amount. Private equity firm GTCR made the investment via Maravai LifeSciences management partnership with C... |
Show more